Somnomed Ltd
ASX:SOM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tata Elxsi Ltd
NSE:TATAELXSI
|
IN |
|
Evergrande Property Services Group Ltd
HKEX:6666
|
CN |
|
M
|
Mira Pharmaceuticals Inc
NASDAQ:MIRA
|
US |
|
K
|
Kojamo Oyj
OMXH:KOJAMO
|
FI |
Somnomed Ltd
Accounts Payable
Somnomed Ltd
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
Accounts Payable
AU$16.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Accounts Payable
AU$6.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
15%
|
|
|
Cochlear Ltd
ASX:COH
|
Accounts Payable
AU$281.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Accounts Payable
AU$847.8k
|
CAGR 3-Years
-1%
|
CAGR 5-Years
14%
|
CAGR 10-Years
5%
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Accounts Payable
AU$11.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Accounts Payable
AU$691.9k
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Somnomed Ltd
Glance View
SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. SomnoMed has developed the SomnoDent, a collection of oral devices. SomnoDent includes two product line, such as signature line and standard line. Its signature line products include Herbst Advance Elite, Fusion, Flex and Classic, and standard line products include Herbst Advance, Air/Air+, Morning Repositioner and Alpha. SomnoMed has developed the SomnoBrux, a custom fit acrylic occlusal splint. SomnoBrux product includes Michigan. SomnoMed has developed the SomGauge, is an autoclavable instrument, which can be used to construct accurate and reliable bite records.
See Also
What is Somnomed Ltd's Accounts Payable?
Accounts Payable
16.6m
AUD
Based on the financial report for Dec 31, 2025, Somnomed Ltd's Accounts Payable amounts to 16.6m AUD.
What is Somnomed Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
12%
Over the last year, the Accounts Payable growth was 8%. The average annual Accounts Payable growth rates for Somnomed Ltd have been 12% over the past three years , 7% over the past five years , and 12% over the past ten years .
